Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avalo Therapeutics (AVTX) Prepaid Assets (2016 - 2025)

Avalo Therapeutics' Prepaid Assets history spans 12 years, with the latest figure at $6.9 million for Q4 2025.

  • For Q4 2025, Prepaid Assets rose 59.84% year-over-year to $6.9 million; the TTM value through Dec 2025 reached $6.9 million, up 59.84%, while the annual FY2025 figure was $6.9 million, 59.84% up from the prior year.
  • Prepaid Assets reached $6.9 million in Q4 2025 per AVTX's latest filing, up from $2.1 million in the prior quarter.
  • In the past five years, Prepaid Assets ranged from a high of $6.9 million in Q4 2025 to a low of $100000.0 in Q1 2024.
  • Average Prepaid Assets over 5 years is $1.9 million, with a median of $1.7 million recorded in 2021.
  • Peak YoY movement for Prepaid Assets: crashed 93.85% in 2024, then skyrocketed 1803.0% in 2025.
  • A 5-year view of Prepaid Assets shows it stood at $2.4 million in 2021, then tumbled by 45.62% to $1.3 million in 2022, then crashed by 61.24% to $500000.0 in 2023, then surged by 765.0% to $4.3 million in 2024, then soared by 59.84% to $6.9 million in 2025.
  • Per Business Quant, the three most recent readings for AVTX's Prepaid Assets are $6.9 million (Q4 2025), $2.1 million (Q3 2025), and $1.9 million (Q2 2025).